Title page(s)
Key passage(s)
Whole article
Download the full article as a PDF
Other material(s)
Full set of peer review & editorial comments going back to A047 and A46:
The predecessor reviews to A159 are available here:
http://www.bmj.com/content/suppl/2014/04/09/bmj.g2545.DC1/jeft017746.ww8_default.pdf
All the clinical study reports used in the A159 review are available here:
http://dx.doi.org/10.5061/dryad.77471
A brief explanation of the background:
http://blog.datadryad.org/?p=2358&shareadraft=534ee77873153#
Additional material made available in May 2016:
Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data” has now been published in the HTA journal on the NIHR Journals Library website and can be downloaded here:
https://www.journalslibrary.nihr.ac.uk/hta/hta20420/#/abstract
See also the timeline of the story since publication of the original Cochrane review in 2014:
http://www.cebm.net/timeline-events-since-publication-cochrane-review-neuraminidase-inhibitors/
See correspondence up to 2014 on bmj.com/tamiflu
See also BMJ coverage:
Debate on whether Tamiflu prevents flu deaths reignites after new analysis:
BMJ 2016; 353 doi: http://dx.doi.org/10.1136/bmj.i3077 (Published 01 June 2016) Cite this as: BMJ 2016;353:i3077